Gitlab (GTLB)
(Delayed Data from NSDQ)
$59.87 USD
-1.28 (-2.09%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $59.88 +0.01 (0.02%) 7:26 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$59.87 USD
-1.28 (-2.09%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $59.88 +0.01 (0.02%) 7:26 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
Zacks News
3 Internet Software Stocks to Buy From a Prospering Industry
by Aniruddha Ganguly
The Zacks Internet software industry participants like Datadog (DDOG), monday.com (MNDY) and Gitlab (GTLB) are benefiting from high demand for SaaS due to the increasing need for remote working, learning, and diagnosis software, as well as cybersecurity applications.
Netflix and CVS Health have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Netflix and CVS Health have been highlighted as Zacks Bull and Bear of the Day
Does GitLab's (GTLB) Growing Clientele Make the Stock a Buy?
by Aniruddha Ganguly
GitLab (GTLB) is benefiting from an expanding clientele, driven by the strong adoption of its DevSecOps platform and a robust partner base.
Gitlab (GTLB) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Gitlab (GTLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Gitlab (GTLB) is Poised for a Turnaround After Losing -16.61% in 4 Weeks
by Zacks Equity Research
The heavy selling pressure might have exhausted for Gitlab (GTLB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Do Options Traders Know Something About GitLab (GTLB) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to GitLab (GTLB) stock based on the movements in the options market lately.
GitLab (GTLB) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
GitLab's (GTLB) first-quarter fiscal 2025 results benefit from solid subscription revenue growth driven by expanding clientele.
GitLab Inc. (GTLB) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Gitlab (GTLB) delivered earnings and revenue surprises of 175% and 2.13%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
PagerDuty (PD) Q1 Earnings Top Estimates
by Zacks Equity Research
PagerDuty (PD) delivered earnings and revenue surprises of 30.77% and 0.51%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Gitlab (GTLB) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Gitlab's (GTLB) first-quarter fiscal 2025 results are likely to reflect the solid performance of the DevSecOps platform, driven by expanding clientele.
GitLab Inc. (GTLB) Stock Moves -0.97%: What You Should Know
by Zacks Equity Research
In the most recent trading session, GitLab Inc. (GTLB) closed at $52.94, indicating a -0.97% shift from the previous trading day.
GitLab Inc. (GTLB) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
GitLab Inc. (GTLB) concluded the recent trading session at $53.36, signifying a +1.7% move from its prior day's close.
GitLab Inc. (GTLB) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw GitLab Inc. (GTLB) settling at $56.38, representing a +0.53% change from its previous close.
GitLab Inc. (GTLB) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
The latest trading day saw GitLab Inc. (GTLB) settling at $52.56, representing a -1.78% change from its previous close.
Here's Why GitLab Inc. (GTLB) Fell More Than Broader Market
by Zacks Equity Research
In the latest trading session, GitLab Inc. (GTLB) closed at $57.07, marking a -1.79% move from the previous day.
GitLab (GTLB) Boosts Security Solutions With Oxeye Acquisition
by Zacks Equity Research
Gitlab (GTLB) boosts DevSecOps with the Oxeye acquisition, enhancing SAST capabilities for streamlined security.
GitLab (GTLB) Posts Gain in Q4, Beats Revenue Estimates
by Zacks Equity Research
GitLab's (GTLB) fiscal fourth-quarter results benefit from solid subscription revenue growth driven by expanding clientele.
GitLab (GTLB) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
GitLab's (GTLB) fourth-quarter fiscal 2024 results are likely to reflect the solid performance of the DevSecOps platform, driven by expanding clientele.
New Strong Buy Stocks for January 22nd
by Zacks Equity Research
POWL, GT, ZUO, GTLB and SNAP have been added to the Zacks Rank #1 (Strong Buy) List on January 22, 2023.
GitLab (GTLB) Expands AI Momentum With the Latest Duo Launch
by Zacks Equity Research
GitLab's (GTLB) Duo Pro, priced at $19 per user monthly, transforms code collaboration and bolsters security with AI-driven DevSecOps, set to launch in February 2024.
Top Stock Picks for Week of January 15, 2024
by Panel Of Zacks Experts
An Interesting Mid Cap Stock and a Small-Cap Provider of Cancer Genetics Diagnostics for Your Consideration.
The Zacks Analyst Blog Highlights DaVita, monday.com, GitLab, Light & Wonder and Sarepta Therapeutics
by Zacks Equity Research
DaVita, monday.com, GitLab, Light & Wonder and Sarepta Therapeutics are part of the Zacks top Analyst Blog.
5 Mid-Cap Stocks to Buy in a Volatile January
by Nalak Das
We have narrowed our search to five mid-caps that have strong potential for 2024. These are: DVA, MNDY, GTLB, LNW, SRPT.
Best Momentum Stocks to Buy for January 4th
by Zacks Equity Research
IMGN and GTLB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 4, 2024.
New Strong Buy Stocks for January 4th
by Zacks Equity Research
IMGN, GTLB, FNWD, BL and TMHC have been added to the Zacks Rank #1 (Strong Buy) List on January 4, 2024.